NCT06842576 · Children's Hospital Los Angeles
Health Care Transition Readiness Short-Form Video Intervention
What this study is about
The goal of this clinical trial is to assess whether social-media style short-form health education videos can increase health care transition readiness, self-effectiveness, emotional well-being, health literacy, and appointment attendance, compared with publicly available health education resources in adolescents with chronic illnesses.
View original scientific description
The goal of this clinical trial is to assess whether social-media style short-form health education videos can increase health care transition readiness, self-efficacy, emotional well-being, health literacy, and appointment attendance, compared with publicly available health education resources in adolescents with chronic illnesses. The main question it aims to answer is: -Hypothesize social media intervention will increase health care transition readiness, self-efficacy, emotional well-being, health literacy, and appointment attendance compared to publicly available health education website immediately post intervention and at 6 month follow up. Participants will be randomly assigned to one of the interventions and access the intervention for 20 minutes and complete 30-60 minutes of surveys.
Interventions
BEHAVIORAL
Health Education Videos
Participants will be prompted to explore the 7 health education videos for up to 20 minutes.
BEHAVIORAL
GotTransition.org Website
Participants will be prompted to explore the Gottransition.org website for up to 20 minutes
Primary outcome measures
Self-reported score with a range from 1-5, on the Transition Readiness Assessment Questionnaire (TRAQ).
Time frame: Immediate post-treatment and 6-month follow-up.
The TRAQ assesses the readiness of youth and young adults to transition from pediatric to adult healthcare. It includes items related to managing medications, appointment keeping, tracking health issues, and communicating with healthcare providers.
Self-reported score ranging from 1 to 4, via the Generalized Self-Efficacy Scale (GSES).
Time frame: Immediate post-treatment and 6-month follow-up.
The GSES evaluates an individual's belief in their ability to cope with a variety of difficult demands in life. It consists of 10 items, each rated on a 4-point scale, assessing confidence in handling unexpected events and solving problems.
Self-reported score ranging from 1 to 5, via the Positive and Negative Affect Schedule for Children and Adolescents (PANAS-C).
Time frame: Immediate post-treatment and 6-month follow-up.
The PANAS-C measures positive and negative affect in children and adolescents. It includes items that assess the extent to which individuals experience various positive and negative emotions over the past few weeks.
Self-report questionnaire with a score ranging from 10 to 40, via the Health Literacy for Youth.
Time frame: Immediate post-treatment and 6-month follow-up.
The HLSAC measures subjective health literacy in youth, focusing on their ability to access, understand, and use health information to make informed decisions.
Number of appointments attended divided by the number of appointments scheduled, producing a score ranging from 0 to 100%, via medical chart abstraction.
Time frame: Comparing 6 months before intervention to 6 months after intervention.
This measure calculates the percentage of scheduled medical appointments that were attended by the patient, providing insight into adherence to treatment plans and engagement with healthcare services.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Patients in subspecialty clinics
- Between 12 and 17 years old
- With access to an internet-connected device
- Speaking English or Spanish
- With sufficient cognitive capacity to understand the study procedures, as assessed via a teach back method.
Where
- Los Angeles, California
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced May 12, 2026 · Source of record for eligibility and locations